Parkwalk Advisers
Founded in London in 2009, Parkwalk is a specialist investor in deeptech spin-offs created at UK universities. Parkwalk currently has over £375m of assets under management and has invested in over 100 companies to date, emanating from the universities in Oxford, Cambridge, Imperial and Bristol, becoming the UK’s most active VC outside London. It currently has 143 portfolio companies, Its recent investments include the $17m May 2021 Series A round of cell therapy medtech Mogrify and in the April 2021 £1.9m seed round of HexagonFab, a medtech producing analytical lab instruments.
The rest of the content is only available if you are logged in.